Salix Coronary Plaque vs ClearRead CT
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary need is a rapid, in-depth, point-of-care analysis of coronary artery plaque and stenosis directly from CCTA scans. This tool is ideal for clinicians requiring detailed quantification of plaque burden, identification of high-risk plaque features, and precise stenosis assessment to guide immediate patient management decisions.
View Salix Coronary Plaque →Choose ClearRead CT if…
Choose ClearRead CT if your workflow demands enhanced detection and tracking of pulmonary nodules across various CT scan types, coupled with opportunistic coronary artery calcification scoring from ungated, non-contrast CTs. This solution is best suited for radiologists seeking to improve diagnostic accuracy and reduce reading times for both lung nodule surveillance and general cardiothoracic health screening.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | ClearRead CT |
|---|---|---|
| Pricing | Subscription model | Contact for pricing |
| Deployment | Cloud-based (Amazon Web Services), web-based software application | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Salix Coronary PlaqueTool A, Salix Coronary Plaque, is a web-based software offering near real-time, point-of-care assessment, which enhances accessibility and immediate clinical utility. Its integrated workflow management and automated report generation further streamline the user experience. While Tool B also aims to improve workflow, Tool A's explicit web-based and point-of-care nature suggests a slightly more direct and accessible integration into clinical practice.
Clinical Value
ClearRead CTTool B, ClearRead CT, provides a broader clinical scope by enhancing both pulmonary nodule detection and coronary artery calcification analysis. It boasts a significant 29% reduction in missed actionable nodules and offers patented vessel suppression technology, demonstrating a quantifiable improvement in diagnostic accuracy. While Tool A offers detailed plaque analysis, Tool B's proven impact on reducing missed actionable nodules across multiple cardiothoracic applications gives it an edge in demonstrated clinical efficacy.
Pricing & Value
Salix Coronary PlaqueTool A, Salix Coronary Plaque, offers greater transparency by explicitly stating a 'Per-scan assessment model' linked to a US CPT reimbursement rate of US$950 per assessment. This provides a clear pathway for potential revenue generation and return on investment for healthcare providers. Tool B only states 'contact vendor for details,' offering no specific pricing model or reimbursement information.
Enterprise Readiness
ClearRead CTTool B, ClearRead CT, offers flexible deployment options, including both on-premise (stand-alone server, virtual machine) and cloud, catering to diverse enterprise IT infrastructures. Its operation with the VA and other healthcare institutions strongly indicates robust enterprise readiness and adherence to necessary compliance standards. Tool A is cloud-only, which may limit its suitability for organizations with strict on-premise requirements.
Innovation
ClearRead CTTool B, ClearRead CT, stands out with its 'Patented Vessel Suppression (Clear Visual Intelligence)' technology, which is a unique and innovative approach to improving nodule detection by reducing visual clutter. This directly contributes to its stated improved detection accuracy. While Tool A's identification of high-risk plaque features is innovative, Tool B's patented technology represents a distinct technological advancement with a clear impact on diagnostic performance.
Support & Docs
ClearRead CTTool B, ClearRead CT, explicitly provides a dedicated 'Support' section on its website, including a customer success hotline, email, support ticket submission, FAQs, and access to user manuals and documentation. This demonstrates a clear commitment to comprehensive customer support. For Tool A, while a user guide is mentioned, a similarly structured and publicly accessible support portal with multiple contact options is not as readily apparent from available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | ClearRead CT |
|---|---|---|
| Product Name | Salix Coronary Plaque | ClearRead CT |
| Company | Artrya Limited | RIVERAIN TECHNOLOGIES |
| Primary Clinical Focus | Coronary artery plaque and stenosis assessment from CCTA scans. | Pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Coronary Artery Plaque Analysis | Detection and quantification of coronary plaque (atherosclerosis), identification of high-risk plaque features. | Not specified |
| Pulmonary Nodule Detection | Not specified | Pulmonary Nodule Detection (solid, part-solid, ground glass), characterization, measurement, tracking. |
| Coronary Artery Calcification (CAC) Scoring | Quantification of calcifications (calcium scoring) | Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs) |
| Stenosis Assessment | Stenosis assessment | Not specified |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and ClearRead CT.